Fountain syndrome

From WikiMD's WELLNESSPEDIA

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's weight loss doctor NYC
Philadelphia GLP-1 weight loss and GLP-1 clinic NYC

Fountain syndrome
Synonyms
Pronounce
Specialty Medical genetics
Symptoms Intellectual disability, growth retardation, craniofacial dysmorphism, hearing loss, skeletal abnormalities
Complications N/A
Onset
Duration
Types
Causes Genetic mutation
Risks
Diagnosis Clinical evaluation, genetic testing
Differential diagnosis
Prevention
Treatment Supportive care, symptomatic treatment
Medication
Prognosis
Frequency
Deaths


Fountain syndrome is a rare genetic disorder characterized by a combination of intellectual disability, hearing loss, growth retardation, and facial dysmorphism. The syndrome was first described in the medical literature in the late 20th century and is named after the physician who identified it.

Clinical Features[edit]

Individuals with Fountain syndrome typically present with the following clinical features:

Genetics[edit]

Fountain syndrome is believed to follow an autosomal recessive inheritance pattern. This means that an individual must inherit two copies of the mutated gene, one from each parent, to be affected by the disorder. The specific gene or genes involved in Fountain syndrome have not yet been definitively identified.

Diagnosis[edit]

The diagnosis of Fountain syndrome is primarily based on clinical evaluation and the identification of characteristic features. Genetic testing may be used to support the diagnosis, particularly in cases where there is a family history of the disorder.

Management[edit]

There is currently no cure for Fountain syndrome, and treatment is primarily supportive and symptomatic. Management strategies may include:

Prognosis[edit]

The prognosis for individuals with Fountain syndrome varies depending on the severity of the symptoms. Early intervention and supportive care can improve the quality of life for affected individuals.

See Also[edit]

References[edit]

External Links[edit]

-


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.